BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28588002)

  • 1. Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification.
    Mahmood R; Altaf C; Ahmed P; Khan SA; Malik HS
    Turk J Haematol; 2018 May; 35(2):109-115. PubMed ID: 28588002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal abnormalities in primary myelodysplastic syndrome.
    Rashid A; Khurshid M; Shaikh U; Adil S
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):632-5. PubMed ID: 25233965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on prognostic significances of different cytogenetic risk categories in patients with primary myelodysplastic syndromes].
    Qu SQ; Liu XP; Xu ZF; Zhang Y; Qin TJ; Zhang TJ; Cui R; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):819-24. PubMed ID: 22339954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
    Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
    Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of Myelodysplastic Syndrome in Patients Evaluated for Cytopenia(s). A Report from a Reference Centre in Saudi Arabia.
    AlMozain N; Mashi A; Alneami Q; Al-Omran A; Bakshi N; Owaidah T; Khalil S; Khogeer H; Hashmi S; Al-Sweedan S; Morris T; AlNounou R
    Hematol Oncol Stem Cell Ther; 2022 Jun; 15(2):39-44. PubMed ID: 33227261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.
    Wall M
    Methods Mol Biol; 2017; 1541():209-222. PubMed ID: 27910026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH).
    Auger N; Douet-Guilbert N; Quessada J; Theisen O; Lafage-Pochitaloff M; Troadec MB
    Curr Res Transl Med; 2023; 71(4):103409. PubMed ID: 38091642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes.
    Wang J; Ai X; Qin T; Xu Z; Zhang Y; Liu J; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Cai W; Ru K; Jia Y; Huang G; Xiao Z
    Oncotarget; 2017 Jan; 8(1):1603-1612. PubMed ID: 27906673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.
    Solé F; Luño E; Sanzo C; Espinet B; Sanz GF; Cervera J; Calasanz MJ; Cigudosa JC; Millà F; Ribera JM; Bureo E; Marquez ML; Arranz E; Florensa L
    Haematologica; 2005 Sep; 90(9):1168-78. PubMed ID: 16154839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities.
    Gurney M; Patnaik MM; Hanson CA; Litzow MR; Al-Kali A; Ketterling RP; Tefferi A; Gangat N
    Br J Haematol; 2017 Jul; 178(1):57-60. PubMed ID: 28419466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical prognostic factors for survival and risk of progression to acute myeloid leukemia in patients with myelodysplastic syndromes with < 10% marrow blasts and non-unfavorable cytogenetic categories.
    Falantes JF; Calderón C; Márquez Malaver FJ; Alonso D; Martín Noya A; Carrillo E; Martino ML; Montero I; González J; Parody R; Espigado I; Pérez-Simón JA
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):144-52. PubMed ID: 23137720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicohematological and cytogenetic profile of myelodysplastic syndromes in Pakistan-compare and contrast.
    Anwar N; Arshad A; Nadeem M; Khurram S; Fatima N; Sharif S; Shan S; Shamsi T
    Mol Cytogenet; 2017; 10():17. PubMed ID: 28491138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of Cytogenetic Characteristics and Clinical Prognosis in 236 Patients with Myelodysplastic Syndrome].
    Xia JY; Wang Y; Li DP; Li ZY; Qiu TT; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1190-1195. PubMed ID: 31418378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [WHO classification and cytogenetic analysis of 435 cases with myelodysplastic syndrome].
    Wang XQ;
    Zhonghua Nei Ke Za Zhi; 2008 Jun; 47(6):464-7. PubMed ID: 19040061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the karyotype abnormalities and its prognostic in 298 patients with myelodysplastic syndrome].
    Yan X; Wei J; Wang J; Ren Y; Zhou X; Mei C; Ye L; Xie L; Hu C; Jin J; Tong H
    Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):297-301. PubMed ID: 25916290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: a multicenter study.
    Wang H; Wang X; Xu X; Lin G
    Ann Hematol; 2010 Jun; 89(6):535-44. PubMed ID: 19921190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of chromosome karyotype between myelodysplastic syndrome and acute leukemia patients confirmed at the same period].
    Jiang M; Wen BZ; Li L; Chen S; Cheng H; Hao JP; Chen R; Wang L; Zhao F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):387-92. PubMed ID: 24763010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of cytogenetic categories in the Revised International Prognostic Scoring System on the prognosis of primary myelodysplastic syndromes: results of a single-center study.
    Qu S; Xu Z; Zhang Y; Qin T; Zhang T; Cui R; Xiao Z
    Leuk Lymphoma; 2012 May; 53(5):940-6. PubMed ID: 22023524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytogenetic profile in patients with primary myelodysplastic syndrome].
    Gritsaev SV; Martynkevich IS; Petrova EV; Martynenko LS; Ivanova MP; Aksenova VIu; Tsybakova NIu; Potikhonova NA; Abdulkadyrov KM
    Ter Arkh; 2013; 85(7):43-9. PubMed ID: 24137946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.
    Chaubey R; Sazawal S; Dada R; Mahapatra M; Saxena R
    Indian J Med Res; 2011 Oct; 134(4):452-7. PubMed ID: 22089606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.